Brain tumours constitute the second most common malignancy in children <15 years of age and the second most common cause of death in children [1] . Whereas supratentorial tumours are more common in children <3 years of age, posterior fossa tumours are more common in children 4-10 years old, and both locations are equally common in children after 10 years of age [2, 3] . Clinical presentations depend on the location, size, and extent of the lesion, and are usually secondary to direct compression of underlying brain parenchyma, mass effect causing shift of intracranial contents, raised intracranial pressure, or focal cerebral ischemia. However, symptoms may be nonspecific and include headache, ataxia, nausea, vomiting, weakness, gait disturbance, seizures, torticollis, and visual or speech changes. Although usually insidious, acute presentations due to stroke or obstruction of cerebrospinal fluid flow can occur.
In this paper, we review the imaging appearances and approach to the differential diagnosis of some of the common supratentorial and posterior fossa tumours in children, selected based either on high prevalence or aggressiveness. We provide a broad overview of the imaging features of these selected tumours, which a general radiologist in practice or resident in training is likely to come across, along with the most likely differentials for each, although this is by no means an exhaustive compilation. Where there are unique features in the clinical presentation these will be discussed within the tumourspecific text, to act as a diagnostic aid. Although outside the scope of this basic review paper, effort has been taken wherever needed to reflect the recently added information relative to 2016 World Health Organization (WHO) classification of brain tumours including the relevance of molecular biology in management of some of these tumours [4] .
Supratentorial Tumours
Optic Pathway Glioma
Epidemiology and presentation
Optic pathway gliomas (OPGs) are WHO grade I tumours that account for approximately 15% of all supratentorial tumours in the pediatric population, and >75% are diagnosed in the first decade of life [5] . OPG affect 11%-30% of children with neurofibromatosis type 1 (NF1) [6] . Patients can be asymptomatic or present with visual loss, proptosis, strabismus, or endocrine or hypothalamic disturbance, depending on the location along the optic pathway. Histologically, the majority are pilocytic astrocytomas. Pediatric OPG are usually indolent whereas presentation in the non-NF1 general population is often more aggressive [7] . Management approaches include observation, chemotherapy, radiation, or surgery [4, 8] . The rapidly improving understanding of molecular markers and newer treatment strategies based on tumour biology has resulted in a paradigm shift in management of these tumours [9] . Prognosis is generally favorable, with a high degree of variability based on histology. In addition, the presence of NF1 and an anterior location are associated with a more favorable prognosis, whereas younger age at presentation is associated with a poorer prognosis [10] .
Imaging
OPGs most often present as a mass causing enlargement, buckling, or kinking of the optic nerve, apparent as an isodense mass with variable enhancement and calcification on computed tomography (CT). Magnetic resonance imaging (MRI) is the preferred imaging modality, with the tumours appearing iso-to hypointense on T1-weighted imaging (WI) and hyperintense on T2WI with variable degrees of enhancement with gadolinium [10, 11] ( Figure 1A and B ). Bilaterality and hydrocephalus are more commonly seen in the setting of NF1, while extraoptic extension into the adjacent basal ganglia and white matter as well as intratumoural cystic areas is more commonly seen in the non-NF1 population.
Differential
The major differential for intraorbital OPG is optic nerve meningioma, which, although more common in adults, tends to be more aggressive if presenting in childhood. On imaging, OPG infiltrates and deforms the optic nerve, whereas with meningioma the optic nerve is visualized on postcontrast imaging with the tumour extending along the nerve, giving the so-called tram-track appearance [12] . Inflammatory diseases such as sarcoidosis, optic neuritis, or inflammatory pseudotumour are also in the differential.
For chiasmatic-hypothalamic OPGs, the main differential diagnosis includes craniopharyngioma, germ cells tumours, and hypothalamic hamartoma [2] . The presence of optic nerve enlargement and NF1 stigmata (clinical features or radiological focal abnormal signal intensity) favor the diagnosis of OPG. On the other hand, the presence of low T2 signal and diffusion restriction, both suggesting high cellularity [3] , are suggestive of germ cell tumours that may also be associated with an additional pineal region tumour. Craniopharyngiomas can sometimes be differentiated from astrocytoma owing to their primary cystic appearance, more calcification, higher T1 signal within the cystic component and by the more heterogeneous appearance of their solid component [13] .
Craniopharyngioma

Epidemiology and presentation
Craniopharyngiomas are common suprasellar or intrasellar tumours, WHO grade I, that account for approximately 5%-10% of all pediatric brain tumours and are believed to arise from remnants of the Rathke pouch [14] . There is a bimodal age distribution of presentation, with a peak in the early second decade and a second peak in the sixth decade [14e16]. Incidence is similar in male and female patients. They can arise anywhere along the pituitary stalk from the floor of the third ventricle to the pituitary gland, or rarely below the sella turcica in the sphenoid sinus, within the path of the embryological craniopharyngeal canal [17] .
Twenty percent of children and 80% of adults present with visual symptoms [18] . Hormonal changes are also likely due to the infundibular position of the tumour with amenorrhea, short stature, delayed puberty, reduced libido, and diabetes insipidus all described. Symptoms may also result from raised intracranial pressure. Although surgery alone is often the therapeutic standard of care, radiation, or intracystic chemotherapy are options for nonresectable tumours. Prognosis is variabledalthough craniopharyngiomas are classified as histologically benign tumours, the 20-year survival is around 60%, but once recurrence occurs, survival rates drop to around 25%. Being <5 years of age at diagnosis, the presence of calcifications, and incomplete tumour resection are associated with worse prognosis [19] .
There are two histological types of craniopharyngioma: adamantinomatous (90%) and papillary (10%), but a mixed variant also exists.
Imaging
In general, craniopharyngiomas are large tumours with suprasellar and intrasellar involvement; 15%-20% are purely suprasellar whereas a purely intrasellar location is very uncommon (<5%) [18, 20] . The papillary subtype may present as a third ventricular lesion. The pediatric variant is usually a solid-cystic mass with a lobulated contour ( Figure 2 ), commonly with calcifications that are usually peripheral (Figure 2A ), except in the papillary subtype, which rarely contains calcification [21] . These features are well seen on CT. On MRI, the cystic components are usually T2 hyperintense ( Figure 2B ) and usually T1 iso-or hyperintense ( Figure 2C ). Moderate enhancement with gadolinium or iodinated contrast agents is common for the solid components or septations ( Figure 2D ).
Differential
The differential for a sella region cystic mass with relative high T1 signal includes Rathke cleft cyst and pituitary adenoma with cystic change or hemorrhage. Rathke cleft cyst is often small, intrasellar, and located immediately anterior to the infundibular insertion [13] . Solid or enhancing components are rare, as are calcifications. Pituitary adenomas are also centered in the sella with extra sellar extension and uncommonly demonstrate calcification, making differentiation between the 2 often very difficult.
Pleomorphic Xanthoastrocytoma
Epidemiology and presentation
Pleomorphic xanthoastrocytoma (PXA) is a low-grade (WHO grade II) astrocytoma [4] . These cortical tumours are most often discovered in young patients undergoing investigation for temporal lobe epilepsy, with approximately 75% of cases presenting with seizures. The peak age of onset is between 10-30 years of age. About half of all PXAs are located in the temporal lobe, abutting the leptomeninges but not directly involving the dura [4] . Neoadjuvant cytoreductive therapy with BRAF or MEK inhibitors is increasingly used to facilitate the surgical excision [22] .
Imaging
The lesion is cortically based and well-circumscribed ( Figure 3 ), often with a peripheral cystic component and demonstrates minimal or absent surrounding oedema with characteristic scalloping of the adjacent bone [23] due to its slow growth ( Figure 3A ). Calcification and hemorrhage are rare [23, 24] . Malignant transformation may occur. These features are usually well depicted on CT. On MRI, the solid portion is usually hypointense on T1WI and iso-to hyperintense on T2WI with avid enhancement following contrast administration [25] ( Figure 3B ).
Differential
The imaging appearance of PXAs can overlap with dysembryoplastic neuroepithelial tumours (DNETs), oligodendroglioma, and ganglioglioma. In young patients < 2 years of age, it might be difficult to distinguish a large PXA from a desmoplastic infantile ganglioglioma or primitive neuroectodermal tumour (PNET) [1] .
Dysembryonic Neuroepithelial Tumour
Epidemiology and presentation
DNETs are slow-growing benign (WHO grade I) tumours arising from cortical grey matter. As such, these tumours are frequently found when investigating the cause of intractable temporal lobe epilepsy. DNETs typically manifest during childhood, adolescence, or young adulthood with a male predilection [4] . Surgical resection is often undertaken to manage the associated seizure activity which can often cease post resection.
Imaging
Useful features in identifying these lesions include a cortical-subcortical location and temporal lobe preponderance (>65% of cases) [4] as well as other features of slowgrowing tumours such as adjacent bone scalloping without erosion and lack of peritumoural vasogenic oedema. CT may demonstrate calcification in 20% of cases [4] . On MRI, a peripheral temporoparietal tumour with minimal or no mass effect, inner table scalloping, and a ''bubbly'' appearance is characteristic. These tumours can show variable heterogeneous enhancement or even a mural nodule [26] . Fluid attenuation inversion recovery (FLAIR) imaging has been shown to demonstrate a ''bright rim sign'' [27] , suggesting gliosis of surrounding white matter (Figure 4 ), while there is no restriction on diffusion-weighted imaging (DWI).
Differential
Ganglioglioma and low-grade glioma are the main differential diagnosis for DNET. However, the FLAIR bright rim and the intratumoural bubbly appearance are considered more suggestive of DNET.
Ganglioglioma
Epidemiology and presentation
Gangliogliomas are low-grade (WHO grade I) central nervous system (CNS) tumours, 70% present in the temporal lobes [23] and associated with epilepsy. They account for 10% of primary intracranial tumours in children. Up to 5% of these lesions can show an aggressive progression and are termed anaplastic gangliogliomas [4, 28] and dedifferentiation to other tumour types can also occur (glioblastoma multiforme or rarely neuroblastoma or PNET). If complete resection is possible, 5-year survival is good, at 97% [4] . Novel therapy targeting the proto-oncogene B-Raf (BRAF) pathways in tumours not amenable to gross total resection offer a valuable alternative [9] .
Imaging
Imaging features are variable, with the most common appearance (40%) of a cyst with focal enhancement. Calcification on CT is seen in approximately 30% [29, 30] of cases, whereas hemorrhage is uncommon. Solid tumours with or without small intratumoural cysts can also occur, with variable enhancement seen in approximately 50% [29, 30] . Commonly there is less peritumoural oedema than expected for the size of the lesion ( Figure 5 ), due to the low-grade nature of the tumour [26] . MRI findings on T1WI and T2WI follow CT patterns, with T2 hyperintense cysts and solid areas that show variable enhancement. There is usually no restriction on DWI. 
Differential
When located in the cerebral cortex or subcortical white matter, the clinicoradiological features of gangliogliomas could overlap with DNET, oligodendroglioma, and PXA.
Choroid Plexus Papilloma and Carcinoma
Epidemiology and presentation
Choroid plexus papilloma (CPP) is a WHO grade I tumour of neuroepithelial origin, accounting for approximately 3% of all intracranial tumours in children [31] . The common sites of these tumours are the lateral ventricles in children and the fourth ventricle in adults [32] . Nearly half manifest in the first decade of life. There is no gender predilection for lateral ventricular CPPs. Extraventricular locations of CPP have also been described.
Choroid plexus carcinoma (CPC) is a WHO grade III tumour, also arising from the choroid plexus usually primarily, and rarely as malignant transformation from a preexisting CPP [33] . They commonly have cerebrospinal fluid (CSF) seeding and as such imaging of the spine is strongly recommended. These are rare tumours, accounting for only 4% of pediatric brain tumours [34] and tend to present before 5 years of age. Clinical features are due to hydrocephalus and raised Intracranial Pressure (ICP) from CSF overproduction, although focal neurological defects, coma, and seizures can also occur. These tumours have a considerably worse prognosis than CPP, with a 26%-50% 5year survival as compared with 100% for resected CPP [35] . The presence of residual disease on postoperative images is an especially poor prognostic factor.
Imaging
On CT, CPPs usually show iso-to-hyperdensity and they show a variable degree of calcification in 25% of cases ( Figure 6A ). On MRI, they can demonstrate a wide variation in signal intensity, with T2 flow voids from large intratumoural vessels and gradient susceptibility in areas of hemorrhage and calcification ( Figure 6B ). The characteristic feature is that of avid enhancement of a lesion in the trigone of the lateral ventricles [36] ( Figure 6C ). Hydrocephalus is common. Although areas of tumoural necrosis, extraventricular extension with parenchymal invasion and white matter oedema are aggressive features suggesting CPC, and these could be seen in CPP as well.
Differential
Differentiation of a CPP from a CPC on imaging is challenging if not impossible, with some CPPs showing aggressive features such as white matter infiltration and CSF seeding. In the fourth ventricle, other tumours to consider would include medulloblastoma (MB), atypical teratoid/ rhabdoid tumour (AT/RT), and ependymomas [13] .
Diffuse Leptomeningeal Glioneuronal Tumour
Epidemiology and presentation
This was previously known as disseminated oligodendroglial-like leptomeningeal tumour of childhood, renamed recently as diffuse leptomeningeal glioneuronal tumour (DLGT) in the 2016 update of the WHO classification of CNS tumours [4] . Although rare, we include it here because of its atypical imaging as a primary tumour. DLGT has not yet be assigned a WHO grade. An accurate prognosis for this diagnosis is yet to be determined. It is unclear if all reported cases are in fact of the one entity as the survival varies widely. Some series reported an average survival of only 22 months [37] , whereas in other series patients have had long-term follow-up [38] .
Regarding immunophenotype, DLGT are negative for neurofilament and epithelial membrane antigen, and have no isocitrate dehydrogenase mutations. Some markers have been identified in DLGT tumours including KIAA1549-BRAF fusion (common), glial fibrillary acidic protein, and synaptophysin [4, 24] .
In the literature, DLGT are commonly reported in patients <18 years of age, with male predominance [4] . These patients usually present with symptoms related to hydrocephalus due to accumulation of tumour within the subarachnoid space. Occasionally, patient may present with focal neurological symptoms, including cranial nerve impairment, ataxia, and spinal cord compression, or with seizures [4, 37] . 
Imaging
CT is usually suboptimal in demonstrating imaging features of DLGT.
On MRI, the dominant finding is a thick nodular leptomeningeal enhancement particularly around the basal cisterns and extending over the surface of the brain and spinal cord [39] . More specifically to this entity are the presence of numerous small subpial cysts of high T2 or FLAIR and low T1 signals, located over the surface or base of bilateral temporal and frontal lobes, and in the posterior fossa (cerebellum and brainstem) and spinal cord [4] . These subpial cysts are felt to represent dilatation of the perivascular spaces (Virchow-Robin spaces) [39] (Figure 7) . Importantly there is often no dominant primary parenchymal mass identified. In many patients, however, discrete intraparenchymal lesions can be identified, most frequently in the spinal cord [4, 39] .
Differential
The differential diagnosis includes leptomeningeal metastasis from another CNS primary tumour and infectious causes such as tuberculous meningitis. However, aforementioned lesions usually are not associated with numerous small subpial cysts which should favor DLGT.
Infratentorial Tumours
Overall, posterior fossa tumours account for 45%-60% of all brain tumours in children [40] . In daily practice, even at very busy tertiary pediatric hospitals, by far the 3 mostencountered posterior fossa tumours in children are juvenile pilocytic astrocytoma (JPA), MBs, and ependymomas, which have different clinical behavior and prognosis, thus mandating an accurate and specific diagnosis. Significant effort has been made to distinguish posterior fossa tumours using molecular biology models that could enable patientspecific tailored management. However high cost and lack of access to genomic subgrouping in most centres around the world constitutes a significant limitation in its routine clinical implementation. On the contrary, imaging of the brain and spine are usually performed in all patients with posterior fossa tumours before treatment to characterize the primary tumour and to aid with surgical neuronavigation, as well as to assess for intracranial and spinal metastasis, which confers to the radiologist a key role and responsibility in the management of these patients.
According to 2016 WHO classification, MB and primary AT/RT are discussed as embryonal tumour [4] . However, to ensure a smooth reading flow in this review article, the 2 tumours are discussed separately.
Cerebellar Astrocytoma
Epidemiology and presentation
Cerebellar astrocytomas account for 10% of all primary brain tumours and up to 25% of posterior fossa tumours in children [41] . Most (70%) cerebellar astrocytomas in children are benign WHO grade I lesions of a specific type called JPA with a peak incidence between 5-15 years and occurring equally frequently in boys and girls [42] . Anaplastic highgrade astrocytomas (WHO III-IV) in children are rare, and more frequently seen in older children or younger adults (usually second decade) [43, 44] .
Patients often present with symptoms and signs of raised intracranial pressure from fourth ventricular obstruction. Waxing and waning early-morning headaches, and vomiting over a period of months [45] . Cerebellar signs including truncal ataxia and dysdiadochokinesia may often be present. Occasionally, intratumoural hemorrhage can lead to acute presentation.
The prognosis of a cerebral astrocytoma depends particularly on the completeness of resection and tumour characteristics including the location, morphology and size. Complete resection, single hemispheric location, small size, and a predominantly cystic tumour with mural nodule are favorable prognostic factors [46] . Patients with JPA have an excellent prognosis with 10-year survival rates more than 90% if completely excised. The newer molecular targets related to the alterations in the RAS/MAPK pathways offer an attractive therapeutic option with BRAF inhibitors in the treatment of pediatric low-grade gliomas [9] .
Imaging
The most common imaging appearance (>50%) is a large cystic cerebellar vermian or hemispheric tumour with a mural nodule. On plain CT, the solid component is usually hypodense to normal white matter. Tumour calcification is rare. On postcontrast CT, cerebellar astrocytomas commonly demonstrate rim enhancement of the cystic component and enhancement of the solid component [47] . The solid component of the JPA usually demonstrates a relatively intense and homogenous postcontrast enhancement [47] . On MRI, the cystic component usually demonstrates low intensity on T1WI and high intensity of T2WI and FLAIR images ( Figure 8A  and B) . On the contrary, high-grade astrocytoma may demonstrate a T2 hypointensity due to high cellularity, mimicking a MB [48] . On DWI, JPA does not show diffusion restriction ( Figure 8C ). On postcontrast T1WI, the enhancement patterns of the solid versus cystic component of an astrocytoma parallel the enhancing pattern seen on contrast-enhanced CT, with an enhancing solid component that may contain internal necrosis as well as the smoothly walled cystic component that may or may not enhance ( Figure 8D ).
Differential diagnosis
The main differential for cerebellar astrocytomas are ependymomas and MBs, which are relatively high cellularity tumours. Consequently, DWI plays a key role, as JPA demonstrates high diffusivity, whereas some ependymomas and most MBs demonstrate diffusion restriction. Unlike JPA, ependymomas often (50%) have calcifications and tend to extend laterally to the cerebellopontine angles.
Brainstem Glioma
Epidemiology and presentation
Diffuse infiltrative pontine gliomas (DIPGs) represent 75%-80% of posterior fossa gliomas in children [49] . Typically, DIPGs are poorly circumscribed, large tumours involving more than 50%-75% of the transverse surface of the pons on initial diagnosis. They are initially located in the ventral or ventrolateral aspect of the pons [50] , and may extend into the adjacent midbrain and medulla. Typically, there is an exophytic component of the tumour extending anteriorly or anterolaterally in the prepontine cistern and surrounding the basilar artery without invading it. Histologically, these tumours are mostly high-grade fibrillary astrocytomas.
Patients with DIPGs typically present with a short clinical history (median 1 month) comprising a triad of symptoms including multiple cranial nerve palsies, pyramidal tract signs, and cerebellar dysfunction (ataxia or nystagmus) [51, 52] . Hydrocephalus is unusual [50] . DIPGs have extremely poor prognosis [53] . The median survival time is 9-12 months despite treatment with conventional radiation therapy. This is explained by the infiltrative nature of these tumours and the location not amenable for surgical resection. However, distinct underlying genetic abnormalities recently identified in the pediatric diffuse gliomas including K27M mutations in the histone H3 gene provides potential targets for therapies [49] .
Imaging
The imaging findings of DIPGs are suggestive of the diagnosis, and thus biopsy is rarely necessary and performed only in cases of unusual imaging appearances or an atypical clinical course [54] . Imaging, especially MRI, allows distinction into focal, dorsally exophytic, cervicomedullary, or diffusely infiltrating tumours. On CT imaging, DIPGs appear as a hypodense expansile mass centered in the pons with occasionally a cystic component ( Figure 9A ). On MRI, DIPGs demonstrate T1 hypointensity and T2 or FLAIR hyperintensity compared with normal parenchyma, with illdefined margins in keeping with the infiltrative nature of the tumour [55] ( Figure 9B and C) . The presence of foci of lower T2 intensity with corresponding diffusion restriction are in keeping with a high cellular density [56] , poorly defined limits on FLAIR, reflecting the infiltrative nature of the tumour [55] , and surrounding oedema; invasion of adjacent segments, hemorrhages [57e59], and necrosis can all be seen. Usually, these tumours show no or minimal enhancement following administration of contrast material [60] ( Figure 9D ). When present, postcontrast enhancement may appear patchy or ring-like.
Differential diagnosis
Typically, the neuroimaging findings of DIPGs are considered pathognomonic and no differential diagnosis is needed.
Medulloblastomas
Epidemiology and presentation
MBs, accounting for 40% of childhood posterior fossa tumours, are highly malignant embryonal neuroepithelial tumours (WHO grade IV) that represent the most common malignant brain tumour in children [61, 62] . MBs have a high propensity for metastatic spread in the neuraxis via cerebrospinal fluid circulation and approximately 20%-35% of patients present with metastatic disease [57, 63, 64] . Although historically considered one disease, it is now clear that they comprise 4 distinct entities termed wingless or WNT, sonic hedgehog or SHH, group 3, and group 4, which have distinct demographics, outcomes, and cells of origin [57, 65, 66] . This molecular subgrouping has outweighed the traditional histological classification which consisted of dividing the MB into classic MB, desmoplastic-nodular MB, and large-cell anaplastic. Within the posterior fossa, location has been shown to be significantly associated with the molecular subgrouping, that is, WNT usually is centered in the lateral recess of the fourth ventricle or in the cerebellopontine angle, SHH in the cerebellar cortex, and the group 3 and group 4 types are centered within the fourth ventricle [67] .
Clinically, 75% of patients with MB are diagnosed before 20 years of age, with a peak incidence between 5-10 years of age.
The clinical history in a patient with MB is usually short with most of them symptomatic for less than a month before diagnosis. Symptoms reflect local mass effect (cerebellar or brainstem) or increased intracranial pressure. Prognostic risk stratification criteria for MB rely primarily on clinicopathological variables, presence of metastases, extent of resection, histological subtypes, and in some instances individual genetic aberrations such as MYC and MYCN amplification [65] . Accordingly, children with MB are classified into 2 distinct groups with different therapy protocols: standard-risk versus high-risk patients, which has an implication in patient management including less intense treatments with reduced therapy-associated side effects. Treatment includes surgery, radiation therapy, and chemotherapy, with long-term survival now achieved in >70% of patients.
Imaging
On unenhanced CT MB appears as a well-circumscribed hyperdense mass in the vermis or cerebellar hemisphere. The hyperdensity of MBs is due to high cellularity. Calcifications, cystic necrosis, and intratumour hemorrhage can be seen [68e70].
On MRI (Figure 10 ), most tumours (regardless of the molecular subgroup) demonstrate low T1 signal, relatively low T2 signal ( Figure 10A ), high FLAIR signal with mild-tomoderate peritumoural vasogenic oedema and often show diffusion restriction ( Figure 10B ) because of high cellularity. Periventricular interstitial oedema could be seen in obstructive hydrocephalus resulting from obstruction of the fourth ventricle. After administration of contrast material, SHH tumours show avid enhancement and group 4 tumours demonstrate minimal or no enhancement ( Figure 10C) , while WNT and group 3 show moderate enhancement [50, 71] . This, associated with the location of the tumour, is very supportive in predicting molecular subgroups.
Differential diagnosis
The main differentials are ependymoma and pilocytic astrocytoma. Tumour extension through the foramina of Luschka and Magendie are considered typical for ependymomas. Pilocytic astrocytomas are most commonly cystic with an enhancing mural nodule, usually without diffusion restriction. In patients <3 years of age, AT/RT should be included in the differential diagnosis. AT/RT, although similar in imaging appearance to MB, are more commonly lateral cerebellar or in the cerebellopontine angles, and can contain intratumoural hemorrhage.
Ependymoma
Epidemiology and presentation
Ependymomas are glial tumours, classified as low grade (WHO grade II) or anaplastic (WHO grade III), that typically arise within or adjacent to the ependymal lining of the ventricular system [72] . Ependymomas constitute the third most common posterior fossa tumour in children after astrocytoma and MB [45] . Ependymomas can develop in the supratentorial brain, in the posterior fossa or in the spinal cord. In the posterior fossa, the typical location is in the fourth ventricle [50] . Ependymomas have a peak incidence in young children (3-5 years of age) [73] . Up to 10% present with CSF seeding.
Patients with posterior fossa ependymomas usually present with a long clinical history including signs of increased cerebral pressure, ataxia, torticollis and lower cranial nerve palsies [74] . The insidious onset of symptoms can contribute to the delay in diagnosis for these patients.
Treatment is surgical with or without adjuvant radiotherapy. The completeness of resection and the age of the patient are considered to have prognostic value [50] . The ongoing advances in molecular biology of these tumours has shown distinct entities in the posterior fossa, supratentorial compartment and the spine. Within the posterior fossa 2 molecular subtypes have been identified and called ependymoma posterior fossa A and ependymoma posterior fossa type B. In the supratentorial compartment 2 subgroups with prototypic gene fusion are named supratentorial ependymoma RELA fusion (ST-EPN-RELA) and ST-EPN-YAP1 fusions [4, 75] .
Imaging
On unenhanced CT, the typical appearance of infratentorial ependymomas is an iso-to hyperdense mass, relative to grey matter, within the fourth ventricle [50] , which may contain punctuate calcifications (50%) ( Figure 11A ), and heterogeneous enhancement following administration of contrast material. On MRI, infratentorial ependymomas appear as a homogenous or heterogeneous mass filling and distending the fourth ventricle, showing T1 iso-or hypointensity and T2 isointensity to grey matter [50] ( Figure 11B ). On T2 or gradient echo, foci of hypointensity can also been seen, in keeping with calcifications or old hemorrhage. Ependymomas typically demonstrate heterogeneous enhancement of the tumour following administration of contrast material [76] (Figure 11C ). An important feature to aid in the identification of an ependymoma is the extension of the tumour through the fourth ventricle outflow foramina [13] . Indeed, approximately 15% of ependymomas extend laterally into the cerebellopontine angles via the foramina of Luschka and about 60% extend via the foramen of Magendie into the cisterna magna, foramen magnum, or even into the upper cervical spinal canal [77] (Figure 11B -D). On DWI, some ependymomas may demonstrate diffusion restriction and others may not ( Figure 11D) , with the former considered more suggestive of anaplastic ependymomas [78, 79] .
Differential diagnosis
The main differential diagnosis for ependymomas include MBs and pilocytic astrocytomas. Although not pathognomonic, the signal pattern on DWI and the appearance of the extension of the tumour through the fourth ventricle outlets can support the diagnosis. Ependymomas commonly do not show diffusion restriction, as compared with MB, which more often do. Although MBs may extend into the lateral recess, their extension shows a bulbous-shaped mass compared with the tonguelike tissue extension seen in ependymomas [80] . Astrocytomas can also extrude through the foramen magnum but they usually originate in the medulla and remain intramedullary while extending into the cervical spine.
Primary AT/RT of Infancy and Childhood
Epidemiology and presentation AT/RT is a rare tumour usually seen in young children (median 2 years of age), 70% seen in the posterior fossa, typically in the cerebellopontine angle or cerebellum, with invasion of surrounding structures. About one-fourth are supratentorial and 8% are multifocal [81] . Similar to MBs, this tumour are can be accompanied with metastasis in the neuraxis at the time of diagnosis, which is seen in a quarter of cases [82] .
Patients with AR/RT may have similar symptoms to those with MB, but with a shorter disease course. Typically, infants present with lethargy, vomiting, and cranial nerve palsies. Hemiplegia or headaches may also be present, as may increasing head circumference [82e84]. In general, the prognosis of patient with AT/RT is poor, with a median survival of 12-14 months and 5-year overall survival <30% [81, 85] . Factors associated with improved prognosis include supratentorial location, localized disease at the time of presentation and complete resection [81, 85] . AT/RT in the new WHO classification is defined by INI1 or BRG1 genetic alterations [4] .
Imaging
On imaging, ARRT can mimic MB both in location and in signal patterns in the posterior fossa, and can mimic PNET and germ cell tumours in the supratentorial brain [86] . On unenhanced CT, AT/RT usually appears iso-to mildly hyperdense to grey matter with intratumour calcification, cystic necrosis or hemorrhage [87] .
On MRI, AT/RT appears as a large mass that demonstrates strikingly heterogeneous signal with the solid component showing T1 hypointensity and T2 iso-to slightly hyperintensity with relatively minimal peritumoural vasogenic oedema ( Figure 12A) [88, 89] . Intratumoural hemorrhage may be seen. The solid component of the tumour shows restriction on DWI ( Figure 12B ). The tumour demonstrates heterogeneous enhancement following administration of contrast material ( Figure 12C ).
Differential diagnosis
The main differential diagnosis for AT/RT is MB in the posterior fossa and PNET and germ cell tumours in the supratentorial brain. It important to distinguish MB and AT/ RT, as the latter does not respond to the standard MB treatment, leading to early death. 
